Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia

Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia

Obstructive sleep apnoea (OSA) is associated with cardiovascular and metabolic comorbidities, including hypertension, dyslipidaemia, insulin resistance and atherosclerosis. Strong evidence suggests that OSA is associated with an altered lipid profile including elevated levels of triglyceride-rich li...

Full description

Bibliographic Details
Main Authors: Martina Meszaros, Andras Bikov
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biomedicines
Subjects:
obstructive sleep apnoea
OSA
dyslipidaemia
lipid
metabolic dysfunction
Online Access:https://www.mdpi.com/2227-9059/10/11/2754

Internet

https://www.mdpi.com/2227-9059/10/11/2754

Similar Items